Lung cancer: screening, diagnosis and management
You must score at least 70% in this module to pass. Ensure you have read ‘Lung cancer: screening, diagnosis and management’ before attempting to complete the module.
This module can be taken up to three times. Once you have passed, you can view the correct answers and download a certificate as a record of your learning.
Additional CPD modules are available in the ‘My CPD’ section of your account.
Quiz Summary
0 of 15 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 15 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- Current
- Review
- Answered
- Correct
- Incorrect
- Question 1 of 15
1. Question
What is the ten-year survival rate for lung cancer?
CorrectIncorrect - Question 2 of 15
2. Question
According to the National Institute for Health and Care Excellence, which of these symptoms is not a red-flag symptom which would necessitate urgent referral to an urgent cancer pathway?
CorrectIncorrect - Question 3 of 15
3. Question
Which of these risks are not linked with lung cancer?
CorrectIncorrect - Question 4 of 15
4. Question
Which technique is invaluable for needling sampling of lymph nodes?
CorrectIncorrect - Question 5 of 15
5. Question
Which of these individuals would be called up for screening for lung cancer, according to the criteria for the national lung cancer screening programme in England
CorrectIncorrect - Question 6 of 15
6. Question
Lung cancer is often asymptomatic until it is advanced. Which symptom below is not a common symptom associated with lung cancer?
CorrectIncorrect - Question 7 of 15
7. Question
Cancer staging is vital in determining many aspects of the care and treatment. Out of the list below what is it not helpful in determining?
CorrectIncorrect - Question 8 of 15
8. Question
In immunohistochemistry for lung cancer, which of the stain results below are not diagnostic of adenocarcinoma?
CorrectIncorrect - Question 9 of 15
9. Question
The treatment for early-stage SCLC can include multiple modalities of treatment. Which of the patients below would potentially be suitable for surgery followed by adjuvant etoposide and cisplatin chemotherapy (EP) and radiotherapy?
CorrectIncorrect - Question 10 of 15
10. Question
Early-stage treatment for NSCLC includes surgery adjuvant chemotherapy and radiotherapy. What statement below is not true about adjuvant osimertinib treatment for NSCLC?
CorrectIncorrect - Question 11 of 15
11. Question
Adjuvant atezolizumab also forms part of the treatment for early-stage NSCLC treatment. What type of agent is atezolizumab?
CorrectIncorrect - Question 12 of 15
12. Question
Which treatment should be offered to fit patients as first-line treatment for extensive stage SCLC?
CorrectIncorrect - Question 13 of 15
13. Question
Which tyrosine kinase inhibitor is not used to treat metastatic ALK gene-addicted NSCLC?
CorrectIncorrect - Question 14 of 15
14. Question
Which of the oncogenic mutations found in lung cancer below are not targetable pharmacologically?
CorrectIncorrect - Question 15 of 15
15. Question
Which patient below would be suitable to receive pembrolizumab/pemetrexed/cisplatin chemotherapy for advanced NSCLC?
CorrectIncorrect